Promising candidate urinary microrna biomarkers for the early detection of hepatocellular carcinoma among high-risk hepatitis C virus Egyptian patients

Journal of Cancer

Volumn 3, Issue 1, 2012, Pages 19-31

  Abdalla, Moemen A K ^a   Haj Ahmad, Yousef ^a  

^a BROCK UNIVERSITY   (Canada)

Author keywords

Biomarkers; Hepatitis C virus; Liver cancer; MicroRNA; Urine

Indexed keywords

ALPHA FETOPROTEIN; MICRORNA; MICRORNA 516; MICRORNA 532; MICRORNA 618; MICRORNA 625; MICRORNA 650; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER GROWTH; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; EGYPT; FEMALE; GENE EXPRESSION PROFILING; GENE TARGETING; HEPATITIS C; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY;

EID: 84871963876     PISSN: None     EISSN: 18379664     Source Type: Journal    
DOI: 10.7150/jca.3.19     Document Type: Article

References (50)

1. Varnholt H, Drebber U, Schulze F, Wedemeyer I, Schirmacher P, Dienes HP, Odenthal M. MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma. Hepatology. 2008; 47: 1223-1232.
2. Steel LF, Mattu TS, Mehta A, Hebestreit H, Dwek R, Evans AA, London WT, Block T. A proteomic approach for the discovery of early detection markers of hepatocellular carcinoma. Dis Markers. 2001; 3: 179-189.
3. Moradpour D, Blum HE. Pathogenesis of Hepatocellular carcinoma. Eur J Gastroenterol Hepatol. 2005; 17: 477-483.
4. Colombo M, Sangiovanni A. Etiology, natural history, and treatment of hepatocellular carcinoma. Antiviral Res. 2003; 60: 145-150.
5. He QY, Zhu R, Lei T, Ng MY, Luk JM, Sham P, Lau GK, Chiu JF. Toward the proteomic identification of biomarkers for the prediction of HBV related hepatocellular carcinoma. J Cell Biochem. 2008; 3: 740-752.
6. Johnson PJ. The role of serum alpha-fetoprotein estimation in the diagnosis and management of hepatocellular carcinoma. Clin Liver Dis. 2001; 5: 145-159.
7. El-Houseini ME, Mohammed MS, Elshemey WM, Hussein TD, Desouky OS, Elsayed AA. Enhanced detection of hepatocellular carcinoma. Cancer Control. 2005; 4: 248-53.
8. Soga K., Watanabe T., Aikawa K., Toshima M., Shibasaki K., Aoyagi Y. Serum des-gamma-carboxyprothrombin level by a modified enzyme immunoassay method in hepatocellular carcinoma: clinical significance in small hepatocellular carcinoma. Hepatogastroenterology. 1998; 45:1737-1741.
9. Steel LF, Mattu TS, Mehta A, Hebestreit H, Dwek R, Evans AA, London WT, Block T. A proteomic approach for the discovery of early detection markers of hepatocellular carcinoma. Dis Markers. 2001; 3: 179-189.
10. Lee JS, Thorgeirsson SS. Comparative and integrative functional genomics of HCC. Oncogene. 2006; 25: 3801-3809.
11. Lemmer ER, Friedman SL, Llovet JM. Molecular diagnosis of chronic liver disease and hepatocellular carcinoma: the potential of gene expression profiling. Semin Liver Dis. 2006; 26: 373-383.
12. Garzon R, Fabbri M, Cimmino A, Calin GA, Croce CM. MicroRNA expression and function in cancer. Trends Mol Med. 2006; 12: 580-587.
13. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993; 75: 843-854.
14. Berezikov E, Thuemmler F, van Laake LW, Kondova I, Bontrop R, Cuppen E, Plasterk RH. Diversity of microRNAs in human and chimpanzee brain. Nat Genet. 2006; 38: 1375-1377.
15. Berezikov E, van Tetering G, Verheul M, van de Belt J, van Laake L, Vos J, Verloop R, van de Wetering M, Guryev V, Takada S, van Zonneveld AJ, Mano H, Plasterk R, Cuppen E. Many novel mammalian microRNA candidates identified by extensive cloning and RAKE analysis. Genome Res. 2006; 16: 1289-1298.
16. Michael MZ, O'Connor SM, Van Holst Pellekaan NG, Young GP, James RJ. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res. 2003; 1: 882-891.
17. Hwang HW, Mendell JT. MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer. 2006; 94: 776-780.
18. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CM. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A. 2006; 103: 2257-2261.
19. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, Rassenti L, Kipps T, Negrini M, Bullrich F, Croce CM. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA. 2002; 99: 15524-15529.
20. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, Calin GA, Liu CG, Croce CM, Harris CC. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell. 2006; 9: 189-198.
21. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR. MicroRNA expression profiles classify human cancers. Nature. 2005; 435: 834-838.
22. Poy MN, Eliasson L, Krutzfeldt J, Kuwajima S, Ma X, Macdonald PE, Pfeffer S, Tuschl T, Rajewsky N, Rorsman P, Stoffel M. A pancreatic islet-specific microRNA regulates insulin secretion. Nature. 2004; 432: 226-230.
23. Van den Berg A, Kroesen BJ, Kooistra K, de Jong D, Briggs J, Blokzijl T, Jacobs S, Kluiver J, Diepstra A, Maggio E, Poppema S. High expression of B-cell receptor inducible gene BIC in all subtypes of Hodgkin lymphoma. Genes Chromosomes Cancer. 2003; 37: 20-28.
24. Voorhoeve PM, le Sage C, Schrier M, Gillis AJ, Stoop H, Nagel R, Liu YP, van Duijse J, Drost J, Griekspoor A, Zlotorynski E, Yabuta N, De Vita G, Nojima H, Looijenga LH, Agami R. A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell. 2006; 124: 1169-1181.
25. Thorgeirsson SS, Grisham JW. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet. 2002; 31: 339-346.
26. Griffiths-Jones S, Grocock RJ, Van Dongen S, Bateman A, Enright AJ. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res. 2006; 34: D140-D144.
27. Cho WC. OncomiRs: the discovery and progress of microRNAs in cancers. Mol Cancer. 2007; 6: 60-12.
28. Esquela-Kerscher A, Slack FJ. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer. 2006; 6: 259-269
29. Murakami Y, Yasuda T, Saigo K, Urashima T, Toyoda H, Okanoue T and Shimotohno K. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene. 2006; 25: 2537-2545.
30. Bravo-Egana V, Rosero S, Molano RD, Pileggi A, Ricordi C, Domínguez-Bendala J and Pastori RL. Quantitative differential expression analysis reveals miR-7 as major islet microRNA. Biochem Biophys Res Commun. 2008; 366: 922-926.
31. Yan FM, Chen AS, Hao F, Zhao XP, Gu CH, Zhaov LB, Yang DL and Hao LJ. Hepatitis C virus may infect extrahepatic tissues in patients with hepatitis C. World J Gastroenterol. 2000; 6: 805-811.
32. Tavazoie SF, Alarcón C, Oskarsson T, Padua D, Wang Q, Bos PD, Gerald WL and Massagué J. Endogenous human microRNAs that suppress breast cancer metastasis. Nature. 2008; 451: 147-152.
33. Bianco R, Troiani T, Tortora G, and Ciardiello F. Intrinsic and acquired resistance to EGFR inhibitors in human cancer therapy. Endocr Relat Cancer. 2005; 12: 159-171.
34. De Jong KP, Stellema R, Karrenbeld A, Koudstaal J, Gouw AS, Sluiter WJ, Peeters PM, Slooff MJ, and De Vries EG. Clinical relevance of transforming growth factor alpha, epidermal growth factor, p53, and Ki67 in colorectal liver metastases and corresponding primary tumors. Hepatology. 1998; 28: 971-979.
35. Liang JL, Wan DS, Pan ZZ and Zhou ZW. Correlations of c-erb-B2, EGFR and TGF-alpha expression to recurrence of Dukes'A and B colorectal carcinoma. Ai Zheng. 2007; 26:647-651
36. Yuan RH, Jeng YM, Chen HL, Lai PL, Pan HW, Hsieh FJ, Lin CY, Lee PH and Hsu C. Stathmin overexpression cooperates with p53 mutation and osteopontin overexpression and is associated with tumour progression, early recurrence and poor prognosis in hepatocellular carcinoma. J Pathol. 2006; 209: 549-558.
37. Harris D, Zhang Z, Chaubey B and Pandey VN. Identification of cellular factors associated with the 3'-nontranslated region of the hepatitis C virus genome. Mol Cell Proteomics. 2006; 5:1006-1018.
38. Camilleri-Broët S, Cremer I, Marmey B, Comperat E, Viguié F, Audouin J, Rio MC, Fridman WH, Sautès-Fridman C and Régnier CH. TRAF4 overexpression is a common characteristic of human carcinomas. Oncogene. 2007; 26:142-147.
39. Nakatsura T, Yoshitake Y, Senju S, Monji M, Komori H, Motomura Y, Hosaka S, Beppu T, Ishiko T, Kamohara H, Ashihara H, Katagiri T, Furukawa Y, Fujiyama S, Ogawa M, Nakamura Y and Nishimura Y. Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker. Biochem Biophys Res Commun. 2003; 306: 16-25.
40. Wright LM, Kreikemeier JT and Fimmel CJ. A concise review of serum markers for hepatocellular cancer. Cancer Detect Prev. 2007; 31: 35-44.
41. Berger J., Bird A. Role of MBD2 in gene regulation and tumorigenesis. Biochem. Soc. Trans. 2005; 33: 1537-1540.
42. Hendrich B, Bird A. Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol Cell Biol. 1998; 18: 6538-6547.
43. Schlegel J, Guneysu S, Mennel HD. Expression of the genes of methyl-binding domain proteins in human gliomas. Oncol Rep..2002; 9: 393-395.
44. Wade PA. Methyl CpG-binding proteins and transcriptional repression. Bioessays. 2001; 23: 1131-1137.
45. Lindahl T, Branes DE. Mammalian DNA ligases. Annu Rev Biochem. 1992; 269: 251-281.
46. Jessberger R, Schar P, Robins P, Ferrari E, Riwar B, Hubscher U. Regulation of DNA metabolic enzymes upon induction of preB cell development and V(D)J recombination: up-reglation of DNA polymerase δ. Nucleic Acids Res. 1997; 25: 289-296.
47. Sun D, Urrabaz R, Kelly S, Nguyen M, Weitman S. Enhancement of DNA ligase I level by gemcitabine in human cancer cells. Clin Cancer Res. 2002; 8: 1189-1195.
48. Qing J, Wei D, Maher VM, McCormick JJ. Cloning and characterization of a novel gene encoding a putative transmembrane protein with altered expression in some human transformed and tumor-derived cell lines. Oncogene. 1999; 18: 335-342.
49. Battle MA, Maher VM, McCormick JJ. ST7 is a novel low-density lipoprotein receptor-related protein (LRP) with a cytoplasmic tail that interacts with proteins related to signal transduction pathways. Biochemistry. 2003; 42: 7270-7282.
50. El-Houseini ME, Mohammed MS, Elshemey WM, Hussein TD, Desouky OS, Elsayed AA. Enhanced detection of hepatocellular carcinoma. Cancer Control. 2005; 4: 248-253.